MarketsandMarkets Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer
View full press release